Illumina Announces Winners of MiSeq® Grant Program
News Nov 08, 2012
Illumina, Inc. has announced the winners of its MiSeq grant program at the American Society of Human Genetics (ASHG) annual meeting in San Francisco.
Illumina received almost 850 applications from researchers in over 40 countries in fields as diverse as microbiology, cancer, inherited disease, and evolutionary biology.
The awardees are:
• Ramunas Stepanauskas, from the Bigelow Laboratory for Ocean Sciences, East Boothbay, Maine, for sequencing single cells from unculturable strains of bacteria in the dark ocean;
• Stephen Doyle, from La Trobe University, Melbourne, Australia, for investigating drug resistance in the causative agent of African river blindness; and
• Karin Haack, from the Texas Biomedical Research Institute, San Antonio, Texas, for targeted resequencing of genes implicated in cardiovascular disease.
"We are excited to broaden access to MiSeq and engage with researchers who are developing novel applications with Illumina technology," said Gary Schroth, Distinguished Scientist at Illumina.
Schroth continued, "The grant applications we received showed an incredible range of creativity. We look forward to working with the grant recipients as they make discoveries, innovate, and accelerate the research being done in their areas of expertise."
The MiSeq grant program was developed to enable any researcher - from novices to current Illumina customers anywhere in the world - to gain access to next generation sequencing (NGS) to further their research, as well as to advance innovation in applications that can only be enabled by NGS capabilities.
Entries were judged by a team of scientific reviewers from Illumina and evaluated based upon scientific merit, originality, and applicability to the unique capabilities of the MiSeq system.
Each of the three winners will receive a MiSeq, sample preparation and sequencing reagent kits, data analysis software and storage, training, and technical support valued at more than $150,000 per prize.
New Approach Identifies Important Undiscovered Functions of ProteinsNews
Scientists have developed a new method to discover which surface contacts on proteins are critical for these cellular interactions. The novel approach shows that essential new functions can be uncovered even for well-studied proteins, and has significant implications for therapeutic drug development, which depends heavily on how drugs physically interact with their cellular targets.READ MORE
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE